Elixxer Stock Today

ELXR Stock  CAD 1.15  0.00  0.00%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 86

 
High
 
Low
Very High
Elixxer is selling for under 1.15 as of the 29th of April 2024; that is No Change since the beginning of the trading day. The stock's lowest day price was 1.15. Elixxer has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Elixxer are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of March 2024 and ending today, the 29th of April 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. ELIXXER is traded on Commodity Exchange in Exotistan. The company has 11.34 M outstanding shares of which 238 shares are currently shorted by private and institutional investors with about 0.67 days to cover all short positions. More on Elixxer

Moving together with Elixxer Stock

  1.0OEE Memex IncPairCorr

Elixxer Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Elixxer's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Elixxer or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ChairmanMazen Haddad
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Elixxer's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Elixxer's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Elixxer's financial leverage. It provides some insight into what part of Elixxer's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Elixxer's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Elixxer deploys its capital and how much of that capital is borrowed.
Liquidity
Elixxer cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has accumulated 4.41 M in total debt with debt to equity ratio (D/E) of 1.96, which is about average as compared to similar companies. Elixxer has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Elixxer until it has trouble settling it off, either with new capital or with free cash flow. So, Elixxer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Elixxer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Elixxer to invest in growth at high rates of return. When we think about Elixxer's use of debt, we should always consider it together with cash and equity.

End Period Cash Flow

106,174
Elixxer (ELXR) is traded on TSX Venture Exchange in Canada and employs 18 people. Elixxer is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Elixxer's market, we take the total number of its shares issued and multiply it by Elixxer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Elixxer operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 11.34 M outstanding shares of which 238 shares are currently shorted by private and institutional investors with about 0.67 days to cover all short positions. Elixxer has accumulated about 969.92 K in cash with (2.35 M) of positive cash flow from operations.
Check Elixxer Probability Of Bankruptcy
Ownership Allocation
Elixxer retains a total of 11.34 Million outstanding shares. 30% of Elixxer outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Elixxer Ownership Details

Elixxer Stock Against Markets

Picking the right benchmark for Elixxer stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Elixxer stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Elixxer is critical whether you are bullish or bearish towards Elixxer at a given time. Please also check how Elixxer's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Elixxer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module

Elixxer Corporate Management

Elected by the shareholders, the Elixxer's board of directors comprises two types of representatives: Elixxer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elixxer. The board's role is to monitor Elixxer's management team and ensure that shareholders' interests are well served. Elixxer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elixxer's outside directors are responsible for providing unbiased perspectives on the board's policies.
David LenigasCo-Chairman of the BoardProfile
Anthony SamahaDirectorProfile
Jeanne WykVice CommunicationsProfile
Michael KozubCorporate SecretaryProfile
Jeff CheahDirectorProfile
John McMullenPresidentProfile

How to buy Elixxer Stock?

Before investing in Elixxer, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Elixxer. To buy Elixxer stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Elixxer. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Elixxer stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Elixxer stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Elixxer stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Elixxer, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Elixxer?

The danger of trading Elixxer is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Elixxer is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Elixxer. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Elixxer is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elixxer. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Elixxer Stock analysis

When running Elixxer's price analysis, check to measure Elixxer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixxer is operating at the current time. Most of Elixxer's value examination focuses on studying past and present price action to predict the probability of Elixxer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixxer's price. Additionally, you may evaluate how the addition of Elixxer to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Please note, there is a significant difference between Elixxer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elixxer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elixxer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.